Dividends Calendar Earnings Calendar
EDIT

EDIT | Editas

Editas

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Massachusetts, United States
  • Number of employees::   89

Company profile

Editas Medicine is building the leading genome editing company dedicated to treating patients with genetically defined diseases.

About the Company

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016.

  • Revenue: 6.05M

Address

11 Hurley Street
Cambridge, MA 02141
United States

  • Total Assets:   508.9 million USD (2019)

Key Persons / Board of Directors

  • CEO :  Katrine S. Bosley


Jump to (Finance sites)

Research 


If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


Consensus
BUY 40
HOLD 40
SELL 20

Their Official Profiles 

WikipediaTwitterLinkedIn

Peers / Similar stocks 

xlv 

Other stocks 

pg orcl wfc hrl rost wmb sptn schw bkng ostk tal mrvl 

Support this project

If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
More features coming soon :)

Social Media 




Recommended Books

Investing For Dummies
Buy on Amazon

In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.